NorthStar issued $37 million in cooperative funding agreements

WisBiz 2

NorthStar Medical Radioisotopes has been issued two cooperative funding agreements worth $37 million by federal officials to boost production of a material widely used in medical imaging.

The material -- known as molybdenum-99 or Mo-99 -- is used to create Technetium-99m. It is used in millions of diagnostic tests each year. NorthStar produces the Mo-99 as well as the systems used for extracting the Tc-99m.

"We are working aggressively to ensure sustainable domestic Mo-99 supply through dual production and processing hubs for additional capacity and scheduling flexibility," said Stephen M...

Please log in to access subscriber content.
If you don't have a subscription, click here for a WisPolitics free trial and to view the different subscription options.
Facebook
Twitter
LinkedIn

Upcoming Events